Affimed Ord Shs (NQ: AFMD )

3.190 USD -0.120 (-3.63%)

Official Closing Price Updated: 4:09 PM EDT, Oct 28, 2020 Add to My Watchlist

Price and Volume

Volume	1,801,800
Open	3.250
Bid (Size)	3.080 (10)
Ask (Size)	3.480 (6)
Prev. Close	3.310
Today's Range	3.090 - 3.280
52wk Range	1.420 - 4.910
Shares Outstanding	29,734,168
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Affimed and NKMax America to Study the Combination of AFM24, an EGFR-Targeted Innate Cell Engager, with SNK01 Natural Killer Cell Therapy

October 20, 2020

Affimed and NKMax America to Study the Combination of AFM24, an EGFR-Targeted Innate Cell Engager, with SNK01 Natural Killer Cell Therapy

October 20, 2020

Performance

YTD	+20.38%	+20.38%
1 Month	-3.92%	-3.92%
3 Month	-11.14%	-11.14%
6 Month	+45.00%	+45.00%
1 Year	+12.72%	+12.72%

More News

Affimed Announces Presentation of Preclinical Data on AFM13-targeted NK cells at the 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

October 14, 2020

Affimed Announces Dosing of First Patient in Phase 1 Clinical Trial of Cord Blood-derived Natural Killer Cells in Combination with the Innate Cell Engager AFM13

October 06, 2020

Affimed to Present at Jefferies Virtual Cell Therapy Summit

September 29, 2020

Affimed to Present at Upcoming Investor Conferences

September 02, 2020

Affimed Reports Second Quarter 2020 Financial Results and Operational Progress

August 11, 2020

Affimed Announces Two New Appointments to Its Supervisory Board

August 05, 2020

Affimed to Report Second Quarter 2020 Financial Results & Corporate Update August 11, 2020

August 04, 2020

Affimed Announces Annual General Meeting of Shareholders

July 10, 2020

Affimed: Q2 Earnings Insights

August 11, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.